Rohan P. Joshi

机构：Tempus Labs (United States) · ORCID：0000-0003-0004-6466

发表论文 59 篇 · 总被引 1412 次 · h-index 14

代表论文

• Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO (2024 · Annals of Oncology · 被引 95)
• Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response (2021 · Nature Cancer · 被引 92)
• A predictive tool for identification of SARS-CoV-2 PCR-negative emergency department patients using routine test results (2020 · Journal of Clinical Virology · 被引 62)
• Loss of PIKfyve in platelets causes a lysosomal disease leading to inflammation and thrombosis in mice (2014 · Nature Communications · 被引 58)
• Targeted deep sequencing of cell‐free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology (2019 · Cancer Cytopathology · 被引 29)
• Multiplexed detection of viral infections using rapid in situ RNA analysis on a chip (2015 · Lab on a Chip · 被引 24)